Globus Medical Q1 revenue down 1.4% to $598.1M; cuts non-GAAP EPS guidance to $3.00-$3.30

GLOBUS MEDICAL INC

2025-Q1 EPS reported $0.54 revenue$598,121,000

GAAP net income $75.5M; GAAP diluted EPS $0.54 vs ($0.05) a year ago.
Non-GAAP diluted EPS $0.68, up 8.5% YoY; prior guidance $3.10-$3.40 now $3.00-$3.30.
Revenue fell 1.4% as-reported (0.8% constant currency); US up 0.2%, Intl down 7.7% as-reported.
Paid off remaining $450M debt from NuVasive merger; Q1 free cash flow $141.2M.
Company cites softer Enabling Technology deals, supply chain disruption, and timing of intl orders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.